Annual Current Liabilities
$37.01 M
+$1.91 M+5.45%
31 December 2023
Summary:
Verve Therapeutics annual total current liabilities is currently $37.01 million, with the most recent change of +$1.91 million (+5.45%) on 31 December 2023. During the last 3 years, it has risen by +$29.69 million (+405.89%). VERV annual current liabilities is now at all-time high.VERV Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$42.64 M
+$2.27 M+5.64%
30 September 2024
Summary:
Verve Therapeutics quarterly total current liabilities is currently $42.64 million, with the most recent change of +$2.27 million (+5.64%) on 30 September 2024. Over the past year, it has increased by +$8.07 million (+23.33%). VERV quarterly current liabilities is now at all-time high.VERV Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | +23.3% |
| 3 y3 years | +405.9% | +110.6% |
| 5 y5 years | - | - |
VERV Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +405.9% | at high | +188.1% |
| 5 y | 5 years | at high | +941.5% | at high | +538.0% |
| alltime | all time | at high | +941.5% | at high | +538.0% |
Verve Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.64 M(+5.6%) |
| June 2024 | - | $40.37 M(+29.0%) |
| Mar 2024 | - | $31.29 M(-15.4%) |
| Dec 2023 | $37.01 M(+5.4%) | $37.01 M(+7.0%) |
| Sept 2023 | - | $34.58 M(+4.7%) |
| June 2023 | - | $33.03 M(-1.6%) |
| Mar 2023 | - | $33.55 M(-4.4%) |
| Dec 2022 | $35.09 M | $35.09 M(+20.9%) |
| Sept 2022 | - | $29.02 M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $25.85 M(+74.6%) |
| Mar 2022 | - | $14.80 M(-32.8%) |
| Dec 2021 | $22.02 M(+201.1%) | $22.02 M(+8.8%) |
| Sept 2021 | - | $20.25 M(+134.1%) |
| June 2021 | - | $8.65 M(+29.4%) |
| Mar 2021 | - | $6.68 M(-8.6%) |
| Dec 2020 | $7.32 M(+105.9%) | - |
| Dec 2020 | - | $7.32 M |
| Dec 2019 | $3.55 M | - |
FAQ
- What is Verve Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Verve Therapeutics?
- What is Verve Therapeutics annual current liabilities year-on-year change?
- What is Verve Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Verve Therapeutics?
- What is Verve Therapeutics quarterly current liabilities year-on-year change?
What is Verve Therapeutics annual total current liabilities?
The current annual current liabilities of VERV is $37.01 M
What is the all time high annual current liabilities for Verve Therapeutics?
Verve Therapeutics all-time high annual total current liabilities is $37.01 M
What is Verve Therapeutics annual current liabilities year-on-year change?
Over the past year, VERV annual total current liabilities has changed by +$1.91 M (+5.45%)
What is Verve Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VERV is $42.64 M
What is the all time high quarterly current liabilities for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total current liabilities is $42.64 M
What is Verve Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VERV quarterly total current liabilities has changed by +$8.07 M (+23.33%)